Comments
Loading...

GlycoMimetics

GLYCNASDAQ
Logo brought to you by Benzinga Data
$0.416000
0.024.16%
At close: -
$0.410700
-0.0053-1.27%
After Hours: 7:57 PM EDT
Q3 2024 Earnings were released on Wed Nov 13th, after the market close

GlycoMimetics (NASDAQ:GLYC) Stock Quotes, Forecast and News Summary

GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jun
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$0.40
Close$0.42
Volume / Avg.1.81M / 18.98M
Day Range$0.39 - $0.44
52 Wk Range0.14 - 3.53
Market Cap$26.48M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
68
Short Interest
12.61%
Days to Cover1

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GLYC
CERO

FAQ

Q

How do I buy GlycoMimetics (GLYC) stock?

A

You can purchase shares of GlycoMimetics (NASDAQ:GLYC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are GlycoMimetics (GLYC) competitors?

Q

What is the forecast, or price target, for GlycoMimetics (GLYC) stock?

A

GlycoMimetics has a consensus price target of $12.00.

Q

What is the current price for GlycoMimetics (GLYC)?

A

The stock price for GlycoMimetics (NASDAQ: GLYC) is $0.4107 last updated November 15, 2024 at 7:57 PM EST.

Q

Does GlycoMimetics (GLYC) pay a dividend?

A

There are no upcoming dividends for GlycoMimetics.

Q

When is GlycoMimetics (NASDAQ:GLYC) reporting earnings?

A

GlycoMimetics’s Q2 earnings are confirmed for Monday, January 6, 2025.

Q

Is GlycoMimetics (GLYC) going to split?

A

There is no upcoming split for GlycoMimetics.

Q

What sector and industry does GlycoMimetics (GLYC) operate in?

A

GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch